Jason Marine Group Limited (SGX:5PF)
0.1500
+0.0050 (3.45%)
At close: Aug 8, 2025
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 0.78 | 0.09 | 0.14 | 0.24 | 0.31 | Upgrade |
Depreciation & Amortization | 1.1 | 0.9 | 0.81 | 0.77 | 0.67 | Upgrade |
Other Amortization | 0.05 | 0.05 | 0.05 | 0.01 | 0.01 | Upgrade |
Loss (Gain) From Sale of Assets | -0 | - | -0 | -0.01 | - | Upgrade |
Asset Writedown & Restructuring Costs | 0.01 | - | 0 | 0 | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.02 | 0.01 | - | - | - | Upgrade |
Loss (Gain) on Equity Investments | 0.03 | -0.05 | -0.03 | 0.01 | 0.01 | Upgrade |
Provision & Write-off of Bad Debts | - | 0 | 0.12 | -0.06 | 0.03 | Upgrade |
Other Operating Activities | 0.64 | -0.16 | 0.39 | 0.37 | 1.35 | Upgrade |
Change in Accounts Receivable | -6.26 | -2.16 | -0.16 | 0.01 | -1.79 | Upgrade |
Change in Inventory | 0.63 | -3.65 | -1.35 | -1.18 | 1.42 | Upgrade |
Change in Accounts Payable | 2.1 | 2.39 | -0.85 | 1.47 | 0.09 | Upgrade |
Change in Unearned Revenue | -0.42 | 0.14 | -0.55 | -0.3 | 0.2 | Upgrade |
Change in Other Net Operating Assets | -0.06 | 0.12 | 0.17 | -0.13 | -0.16 | Upgrade |
Operating Cash Flow | -1.44 | -2.31 | -1.25 | 1.21 | 2.14 | Upgrade |
Operating Cash Flow Growth | - | - | - | -43.37% | 50.88% | Upgrade |
Capital Expenditures | -0.91 | -0.25 | -0.26 | -0.48 | -0.5 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | - | 0 | 0.02 | - | Upgrade |
Sale (Purchase) of Intangibles | -0.01 | -0.12 | -0.2 | - | -0.04 | Upgrade |
Investment in Securities | - | - | 0.24 | - | - | Upgrade |
Other Investing Activities | - | 0.26 | 0.03 | 0.04 | - | Upgrade |
Investing Cash Flow | -0.91 | -0.11 | -0.19 | -0.42 | -0.53 | Upgrade |
Long-Term Debt Issued | 0.54 | 0.91 | - | 5 | - | Upgrade |
Long-Term Debt Repaid | -2.22 | -2.46 | -1.44 | -1.14 | -0.4 | Upgrade |
Net Debt Issued (Repaid) | -1.68 | -1.55 | -1.44 | 3.86 | -0.4 | Upgrade |
Common Dividends Paid | -0.26 | -0.79 | -1.05 | -0.79 | -0.53 | Upgrade |
Other Financing Activities | -0.07 | -0.08 | -0.09 | -0.08 | -0.02 | Upgrade |
Financing Cash Flow | -2.01 | -2.43 | -2.84 | 2.99 | -0.94 | Upgrade |
Foreign Exchange Rate Adjustments | -0.01 | 0.01 | -0.14 | 0.01 | -0.13 | Upgrade |
Net Cash Flow | -4.38 | -4.84 | -4.42 | 3.78 | 0.53 | Upgrade |
Free Cash Flow | -2.35 | -2.56 | -1.51 | 0.73 | 1.64 | Upgrade |
Free Cash Flow Growth | - | - | - | -55.31% | 47.09% | Upgrade |
Free Cash Flow Margin | -4.84% | -7.40% | -4.98% | 2.37% | 5.44% | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.01 | 0.01 | 0.02 | Upgrade |
Cash Interest Paid | 0.07 | 0.08 | 0.09 | 0.08 | 0.02 | Upgrade |
Cash Income Tax Paid | 0.04 | 0.06 | 0.11 | 0.04 | 0 | Upgrade |
Levered Free Cash Flow | -2.63 | -3.13 | -2.24 | 0.27 | 0.69 | Upgrade |
Unlevered Free Cash Flow | -2.59 | -3.07 | -2.18 | 0.32 | 0.7 | Upgrade |
Change in Working Capital | -4.02 | -3.16 | -2.74 | -0.13 | -0.25 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.